Takeda Pharmaceutical Company Limited Changes In Other Provisions
Takeda Pharmaceutical Company Limited (TKPHF) reported Changes In Other Provisions of -JPY 45.17 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:ChangesInOtherProvisions · last filed 2025-06-25
| Period end | Changes In Other Provisions 12 month |
|---|---|
| 2025-03-31 | -45.17B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 126.90B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | -31.90B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 58.09B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | -49.10B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -21.94B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -47.06B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 6.53B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | -20.55B JPY 20-F · filed 2019-06-27 |